Introduction Chromognanins
A and B [for nomenclature see Eiden et al. (1987)] were originally characterized in the adrenal medulla (Fischer-Colbrie and Fnischenschlager, 1985; Smith and Kinschner, 1967; Smith and Winkler, 1967; Helle, 1966) . The observation that chromogranin A is identical to secretory protein I ofthe parathyroid gland (Cohn et al. , 1982) led to many studies demonstrating the widespread distribution of these two acidic proteins in endocrine tissues (Lloyd et al., 1988; Lassmann et al., 1986; Rindi et al., 1986; Facer et al., 1985; Fischer-Colbnie et al., 1985; Rosa et al., 1985; Wilson and Lloyd, 1984; O'Connor et al., 1983) and in the nervous system (Fonss-Petter et al., 1989; Salahuddin et al., 1989; Volknandt et al., 1987; Nolan et al., 1985; Somogyi et al., 1984; Hopwood, 1968 ). In the heart, the secretory granules containing the atnial natniuretic peptides (ANP) provide the basis for the endocrine function ofthis organ (Cantin et al., 1984; Fonssmann et al., 1984; Dc-Bold, 1982) . These secretory vesicles have been characterized by subcellulan fractionation (Eipper et al., 1988; Thibault et al., 1987) and it has been claimed that their major soluble constituent is pro- ANP (Thibault et al., 1987 al., 1987; Yoshie et al., 1987; Hagn et al., 1986; Fischer-Colbnie et al., 1985) . There are two possible explanations: (a) the pro-protein chnomogranin B has already been completely processed by endogenous proteases;
Results

Electron Microscopy
(b) the pro-protein in heart is post-translationally processed in a different way, e.g. , by an altered The auricular myocardiocytes of the heart constitute an endo-
